|
No harms |
Minor harms |
Moderate harms |
Patients had no adverse events of interest |
Patients only had the adverse events that are less worrying including incident cataracts, prescription-requiring hypertension, prescription-requiring hyperlipidemia, or prescription-requiring infections |
Patients had any of the adverse events that are more worrying including incident glaucoma, requiring cataract surgery and requiring glaucoma surgery |
|
With benefits |
(1) With benefits/No harms |
(2) With benefits/Minor harms |
(3) With benefits/Moderate harms |
Patients’ visual acuity of the better-seeing eye remained at better than 20/40 or improved to better than 20/40 |
No benefits |
(4) No benefits/No harms |
(5) No benefits/Minor harms |
(6) No benefits/Moderate harms |
Patients’ visual acuity of the better-seeing eye remained at worse than 20/40 or decreased to worse than 20/40 |
|
|
(7) Missing data |
|
Patients died or were loss to follow-up, or their visual acuity was not or could not be measured |